Agoracom Blog Home

Posts Tagged ‘#smallcaps’

HPQ Silicon Affiliate Patents Can Expand Performance Of Graphite Anodes In Lithium-Ion Batteries And Deliver Holy Grail Silicon Anodes With Up To 10X Energy

Posted by Alavaro Coronel at 2:02 PM on Thursday, November 16th, 2023

In an electric vehicle battery, which is typically a lithium-ion battery, there are three main parts you need to know about: the anode, the cathode, and the electrolyte.h

The anode plays a crucial role in how the battery works. Specifically, it acts like a storage container for lithium ions. It holds onto them when the battery is charged and releases them when the battery is being used to power the car. This flow of lithium ions back is what makes the battery work and allows your EV to run on electric power.

THE CHALLENGE – GRAPHITE ANODES HAVE HIT MAXIMUM PERFORMANCE

Today, graphite anodes dominate the market of anode materials for lithium-ion batteries, with the graphite market estimated to be worth approximately US$25 billion in 2023.

But that may be as far as it goes with graphite having essentially achieved its maximum performance in terms of energy density.

THE SOLUTION – SILICON ANODES CAN INCREASE ENERGY BY 10X

HPQ announced that affiliate Company Novacium SAS has acquired a family of patents related to the surface treatment of carbon-based materials. These innovations come from the world-renowned researcher Dr. Alexander Zaderko, with over two decades of experience.

Silicon-based anodes have up to 10 times the energy density of a graphite-based anode, which is why Porsche, Mercedes and GM are betting on silicon-anode batteries.

THE PROBLEM – CURRENT SILICON ANODES CAN DEGRADE

While silicon-based anode materials hold great promise for batteries, they are known to suffer from significant degradation during charging and discharging cycles.

ENTER HPQ SILICON AND NOVACIUM

Initial tests have shown significant performance improvements in silicon-based Li-ion batteries. These results indicate that the new surface treatment has a dual effect on battery properties:

  • Reduces degradation, enhancing cyclability (battery lifespan)
  • Reduces charging time.

BEYOND SILICON -ENHANCING THE PERFORMANCE OF EXISTING GRAPHITE ANODES & ENTIRE BATTERY MARKET

Furthermore, initial test results with graphite anode materials alone (without silicon) suggest that the new surface treatment positively impacts the performance of graphite-based Li-ion batteries.

“Our innovative approach aims to significantly improve the operation of lithium batteries. We believe the application of Novacium’s patented surface treatments has the potential to transform and enhance the performance of Li-ion batteries, benefiting not only silicon-based anode materials but the entire battery market.”

Oleksiy Nichiporuk, Novacium Chief Technical Officer

HPQ SILICON ALREADY IN DISCUSSION WITH ENTITIES UNDER NDA

“Novacium’s new patented surface treatment, which also improves the performance of graphite-based Li-ion batteries commonly used in the industry, provides HPQ and Novacium with a unique opportunity to offer solutions tailored to both the short- and long-term needs of the battery industry. Promising preliminary discussions have already started to take place with entities already under non-disclosure agreements with HPQ on the potential of this technology.”

Bernard Tourillon, CEO HPQ Silicon Inc. and NOVACIUM SAS

HOW BIG IS THE MARKET POTENTIAL?

In 2023, the market for these materials is estimated to be valued at anywhere between US$1.1 billion and US$2.7 billion.

Projections for the future suggest that the demand for silicon anode materials could reach 300,000 tons by 2030, with an estimated value of around US$15 billion according to one source, and an astounding US$131.6 billion by 2033 according to another.

It’s worth noting that, currently, silicon-based materials for lithium-ion batteries represent a relatively small portion, making up less than 10%, of the overall global demand for graphite.

Novacium’s pioneering surface treatment techniques are on the cusp of reshaping the landscape of lithium-ion batteries, and HPQ Silicon Inc. stands at the vanguard, not merely to meet, but to surpass the energy needs of the future. With their exclusive innovations, the horizons of battery technology are illuminated like never before, providing an enticing preview of what awaits in the realm of sustainable and high-performance energy solutions.

Now sit back, relax and watch this powerful interview.

 

https://youtu.be/Ue2eIeZ8h6k

INDUSTRY BULLETIN: IATA’s Positive Safety Trends Align with Star Navigation Systems’ Ascent

Posted by Aidi Munoz at 11:54 AM on Monday, November 13th, 2023

Industry Outlook and Star Navigation Systems’ Trajectory: The International Air Transport Association’s (IATA) recently released Safety Report for global aviation reflects a positive trend with reduced fatal accidents and a declining fatality risk. As the aviation industry looks towards enhanced safety, Star Navigation Systems stands as a beacon, strategically positioned to leverage and contribute to these advancements.

Voices of Authority: Willie Walsh, IATA’s Director General, emphasizes the significance of continued safety analysis despite aviation’s exceptional safety record. His insights align with Star Navigation Systems’ commitment to advancing aviation safety through cutting-edge technology.

Star Navigation Systems’ Highlights: 

  • Real time engine condition monitoring
  • Take off to landing aircraft, data analysis and fuel insights
  • One stop comprehensive data analysis dashboard
  • Automatic flight data transfer and end of flight reports to operator at end of each flight
  • Automatic black box data transfer from aircraft during distress

Star Navigation Systems is actively collaborating with key partners:

  • Aero Contractors: Advancing LOI with sales agents in Lagos, Nigeria, working to solidify a purchase order contract.
  • Air Peace: Received a proposal request from Nigeria’s Air Peace for Star-ISMS® installation across their fleet.
  • Astral Aviation: Announced the sale of seven aircraft in June 2022, with the project progressing, contributing to revenue streams.
  • Ethiopian Airlines: Submitted a comprehensive proposal to Ethiopian Airlines, covering data transmission, inflight analysis, post-flight tracking, and proactive maintenance capabilities.
  • Nigerian Air Force: Engaged in discussions to modernize the military with cutting-edge hardware and software solutions.
  • LOI with 30B PROJECT: LAPSSET African Infrastructure Project

STAR NAVIGATION HAS ANSWERED THE CALL

Real-world Relevance: In a world where every flight takes off and lands safely, Star Navigation Systems contributes by offering real-time inflight analysis and safety monitoring. Imagine a flight every day for 25,214 years to experience a 100% fatal accident—a testament to the industry’s low risk, made even safer by companies like Star Navigation Systems.

Looking Ahead with Star Navigation Systems: As the aviation industry embraces a risk-based safety model, Star Navigation Systems is at the forefront, aligning its goals with the industry’s commitment to continuous improvement. With a focus on global standards and innovations Star Navigation Systems is set to shape the future of connected aviation.

Conclusion: In the evolving landscape of aviation safety, Star Navigation Systems emerges as a pivotal player, contributing to the industry’s positive trajectory. Investors seeking a blend of technological innovation and industry foresight should closely watch Star Navigation Systems. The company’s commitment to safety aligns seamlessly with the industry’s upward trajectory, making it a compelling prospect for those keen on the future of aviation technology.

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY

Posted by Aidi Munoz at 9:40 AM on Tuesday, September 26th, 2023

Empower Clinics Inc (EPW: CSE) (EPWCF: PINK), a leading healthcare company, is proud to announce a significant milestone in its research and clinical trials division. Its subsidiary, EPW Curesearch LLC (“EPWC”), has successfully secured its inaugural clinical trial from a major European pharmaceutical powerhouse with a staggering market capitalization exceeding $100 billion. This monumental achievement is set to impact the future of healthcare outcomes worldwide.

Building upon its previous announcement on July 31, 2023, which highlighted multiple study applications covering diverse disease states, Empower Clinics confirms that this awarded clinical trial will be dedicated to addressing Chronic Obstructive Pulmonary Disease (COPD). The trial will be spearheaded by one of the company’s most seasoned Principal Investigators (PIs).

The collaboration between Empower Clinics, their PI, and the pharmaceutical sponsor is poised to enroll between 20 to 35 patients, primarily from the existing patient roster, with the recruitment window extending into mid-2024 and the possibility of extensions. Remarkably, there are no restrictions on the maximum number of patients per site, enabling EPWC to source additional participants from external medical centers, hospitals, and various social recruitment channels, including Facebook, Instagram, Twitter, and other digital marketing avenues.

Steven McAuley, Chairman & CEO of Empower Clinics, expressed his enthusiasm, stating, “We are all ecstatic to receive our first awarded clinical trial, a result of consistent and persistent effort over the past number of months. Our focus on partnering with large established medical centers and very experienced medical doctors has proven successful.” He further anticipates additional sponsor due diligence, site visits, and awards in the future.

Empower Clinics has strategically aligned itself with practicing medical doctors, who are specialists in their respective fields and have previous research and clinical trials experience. These PIs play a pivotal role in the success of Empower’s Site Management Organization (SMO), facilitating meaningful revenues from the Biotech and Pharmaceutical industries, providing oversight and support to patients, and acting as a crucial liaison between pharmaceutical companies and Contract Research Organizations (CROs).

While the company continues to navigate through a Cease Trade Order and accounting and audit procedures, the enormous market opportunity beckons. The Clinical Research Organization (CRO) Services Market is set to reach $127.3 billion by 2028, driven by the ever-expanding pharmaceutical, biotechnology, and medical device R&D pipelines, as well as advancements in clinical trial processes. Empower Clinics is positioned to play a pivotal role in this transformative era of healthcare.

About Empower:

Empower is a patient-focused healthcare company committed to making a positive impact on lives and future healthcare outcomes through clinical trials. With two clinical research sites and six principal investigators, Empower operates as a Site Management Organization (SMO) with multiple clinical trials in the pipeline. Additionally, the company has announced its intention to create a healthcare AI spinout focused on enhancing patient identification, recruitment, and onboarding for clinical trials.

Read release: https://www.einpresswire.com/article/657704521/empower-clinics-announces-award-of-first-clinical-trial-from-global-fortune-500-pharmaceutical-company

VIDEO – Delic Owns The Largest Profitable Chain Of Psychedelics Clinics In America – And Is Targeting Hundreds Of Locations Thanks To Patient Acceptance, Legislation And Insurance Support

Posted by Brittany McNabb at 5:51 PM on Thursday, October 20th, 2022

To understand Delic Holdings $DELC $DELCF you first must understand that Psychedelics are going to go through a parabolic, paradigm shifting growth cycle in the next 5 years because of their ability to treat anxiety, depression & other mental illnesses – which have proven to be far superior to traditional pharmaceuticals.  Just look at these numbers:

Response to Ketamine Treatment of Depressive Disorders:

• 80+ % Effective with Bipolar and Depression 

• 76+ % Effective with Major Depressive Disorders

• 65+ % Effective with Depression with PTSD and Anxiety 

• 50+ %  Effective with Borderline Personality Disorder

Compare these to 63% of Americans who have used Rx drugs to treat anxiety, depression and PTSD but say they still have symptoms. 

As incredible as these results are, both $DELC and Psychedelics couldn’t be coming along at a better time given the fact that Mental Health problems are getting exponentially worse after COVID, with 51.5M people in the U.S. having experienced a mental health condition

ENTER DELIC 

$DELC is the largest profitable chain of psychedelics clinics in the United States with 13 locations across 9 states – and 15 more locations coming in the next 18 months

How big is Delic?  The Company’s Ketamine Wellness Centers will serve more patients than any other ketamine therapy provider this year.  Other highlights include:

• $9m+ Revenue Run Rate & EBITDA Positive

• 2021 increase net assets to $10M+ from $2.1M in 2020

• Well capitalized to grow organically and via M&A as industry grows

GROWTH EXPECTED TO REACH HUNDREDS OF CLINICS

$DELC Co-Founder and Executive Chairman, Matt Stang isn’t resting on the Company’s leadership laurels and has set his sights on hundreds of clinics in the coming 5 years thanks to:

• Consumer Acceptance – The Public Is Fully Embracing Psychedelics

• Friendly Legislation –  Legalization Of MDMA & Psilocybin Treatments Is Coming

• Insurance Coverage – The Insurance Industry Is Increasingly Covering Psychedelics Treatments

To this end, Stang points to the Company’s most recent announcements as support for his growth target:

Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO(TM) Coverage

If you believe in the future of psychedelics and want to know more about both the overall industry and Delic itself, then sit back and watch this great interview with Co-Founder and Executive Chairman, Matt Stang

YOUR NEXT $DELC STEPS

$DELC  HUB On AGORACOM: https://agoracom.com/ir/delicholdings

$DELC  5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/delicholdings/profile

$DELC  Official Verified Discussion Forum On AGORACOM:  https://agoracom.com/ir/delicholdings/forums/discussion

Connect With AGORACOM Anyway You Like

AGORACOM YouTube:  Hit That Subscribe Button Right Now For More Powerful Videos

AGORACOM Twitter:  https://www.twitter.com/AGORACOM Verified Top 0.2% Account

AGORACOM Spotify:  https://open.spotify.com/AGORACOM  Planes, Trains, Automobiles & Walking The Dog

AGORACOM Instagram: https://www.instagram.com/agoracomsmallcap/  Each Pic Is Worth 1,000 Words

AGORACOM Linkedin:   https://www.linkedin.com/company/agoracom For The Suits

AGORACOM Tik Tok:  https://www.tiktok.com/@agoracom We Don’t Dance … Promise

AGORACOM Facebook:  https://www.facebook.com/AGORACOM For The Moms and Dads